8-KEarnings & ResultsExhibits & Filings

Medline Inc. 8-K Report, Financial Results (May 6, 2026)

Filed May 6, 2026For Securities:MDLN

Summary

Medline Inc. (MDLN) filed an 8-K on May 6, 2026, to report its financial results for the first quarter ended March 28, 2026. The filing primarily directs investors to an accompanying earnings press release (Exhibit 99.1) for detailed financial performance and operational updates. Investors should refer to this press release for specific figures on revenue, profitability, and any forward-looking statements or management commentary. While the 8-K itself does not contain the financial data, its purpose is to officially announce the release of these results, making them publicly available. The information provided is considered 'furnished' rather than 'filed,' which has implications under SEC regulations regarding liability for forward-looking statements. Investors seeking a comprehensive understanding of Medline's current financial health and outlook should carefully review the press release referenced in this filing.

Key Highlights

  • 1Medline Inc. (MDLN) announced Q1 2026 financial results via an 8-K filing on May 6, 2026.
  • 2The filing references an earnings press release (Exhibit 99.1) for detailed financial information.
  • 3Key performance indicators such as revenue, net income, and margins for Q1 2026 are expected to be found in the press release.
  • 4The 8-K serves as the official notification of the earnings release.
  • 5Information furnished under Item 2.02 is generally not considered 'filed' for Section 18 purposes, impacting potential liability for forward-looking statements.
  • 6Investors are directed to the press release for management's commentary on financial condition and results of operations.

Frequently Asked Questions